Meet the specialists: COVID-19 vaccine for cancer patients Q&A

29th January 2021

Missed our free GatewayC LIVE webinar? Watch our recording here.

In this webinar, GatewayC met Professor Robert Duncombe, Director of Pharmacy at The Christie NHS Foundation Trust and Dr Neil Bayman, Consultant Clinical Oncologist and Associate Medical Director at The Christie NHS Foundation Trust.

Our speakers answered key questions from our audience, which included:

  1. Can patients receiving chemotherapy have the vaccine?
  2. Where are patients receiving the vaccine?
  3. Will cancer inpatients receive vaccinations?
  4. Do we advise patients who have had severe taxol reactions to avoid the Pfizer vaccine?
  5. How (as GPs) are we going to know if someone is clinically vulnerable or about to start treatment?

Find out more:

  • Access GatewayC’s full webinar library here
  • Watch this recorded webinar here
  • Access GatewayC’s Managing Physical Effects course here

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Related Posts

Are COPD symptoms masking a lung cancer?

Are COPD symptoms masking a lung cancer?

Lung cancer is the 3rd most common cancer in the UK, yet the most common route to diagnosis is through emergency presentation. COPD and Lung Cancer Pre-existing conditions, such as Chronic Obstructive Pulmonary Disease (COPD), can increase a person’s risk of lung...

read more